Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()

Detalles Bibliográficos
Autores principales: Portaluri, M., Barba, M.C., Musio, D., Tramacere, F., Pati, F., Bambace, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
COVID-19 Rapid Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329675/
https://www.ncbi.nlm.nih.gov/pubmed/32621832
http://dx.doi.org/10.1016/j.radonc.2020.06.036
_version_ 1783552946417434624
author Portaluri, M.
Barba, M.C.
Musio, D.
Tramacere, F.
Pati, F.
Bambace, S.
author_facet Portaluri, M.
Barba, M.C.
Musio, D.
Tramacere, F.
Pati, F.
Bambace, S.
author_sort Portaluri, M.
collection PubMed
description
format Online
Article
Text
id pubmed-7329675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73296752020-07-02 Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities() Portaluri, M. Barba, M.C. Musio, D. Tramacere, F. Pati, F. Bambace, S. Radiother Oncol COVID-19 Rapid Letter Elsevier B.V. 2020-09 2020-07-02 /pmc/articles/PMC7329675/ /pubmed/32621832 http://dx.doi.org/10.1016/j.radonc.2020.06.036 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle COVID-19 Rapid Letter
Portaluri, M.
Barba, M.C.
Musio, D.
Tramacere, F.
Pati, F.
Bambace, S.
Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title_full Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title_fullStr Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title_full_unstemmed Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title_short Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
title_sort hypofractionation in covid-19 radiotherapy: a mix of evidence based medicine and of opportunities()
topic COVID-19 Rapid Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329675/
https://www.ncbi.nlm.nih.gov/pubmed/32621832
http://dx.doi.org/10.1016/j.radonc.2020.06.036
work_keys_str_mv AT portalurim hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities
AT barbamc hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities
AT musiod hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities
AT tramaceref hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities
AT patif hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities
AT bambaces hypofractionationincovid19radiotherapyamixofevidencebasedmedicineandofopportunities

Ejemplares similares